Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Dai

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Pharmacology Research & Perspectives|December 16, 2014
Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity modelsAlykhan S Motani, Jian Luo, Lingming Liang, et al.
Molecular Cancer Therapeutics|December 10, 2014
AMG 925 is a dual FLT3/CDK4 inhibitor with the potential to overcome FLT3 inhibitor resistance in acute myeloid leukemiaCong Li, Liqin Liu, Lingming Liang, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2011
Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2Xiaoqi Chen, Jeff Mihalic, Pingchen Fan, et al.
Analytical Biochemistry|November 8, 2011
Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitorsMei-Chu Lo, Rachel Ngo, Kang Dai, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2011
Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesityJeffrey T Mihalic, Xiaoqi Chen, Pingchen Fan, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibitionJeffrey T Mihalic, Pingchen Fan, Xiaoqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Identification of piperazine-bisamide GHSR antagonists for the treatment of obesityMing Yu, Mike Lizarzaburu, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agentsHilary P Beck, Todd Kohn, Steven Rubenstein, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of a new class of ghrelin receptor antagonistsJeffrey T Mihalic, Yong-Jae Kim, Mike Lizarzaburu, et al.
Molecular Cancer Therapeutics|February 15, 2014
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemiaKathleen Keegan, Cong Li, Zhihong Li, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Pharmacology Research & Perspectives|December 16, 2014
Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity modelsAlykhan S Motani, Jian Luo, Lingming Liang, et al.
Molecular Cancer Therapeutics|December 10, 2014
AMG 925 is a dual FLT3/CDK4 inhibitor with the potential to overcome FLT3 inhibitor resistance in acute myeloid leukemiaCong Li, Liqin Liu, Lingming Liang, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2011
Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2Xiaoqi Chen, Jeff Mihalic, Pingchen Fan, et al.
Analytical Biochemistry|November 8, 2011
Development of a time-resolved fluorescence resonance energy transfer assay for cyclin-dependent kinase 4 and identification of its ATP-noncompetitive inhibitorsMei-Chu Lo, Rachel Ngo, Kang Dai, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2011
Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesityJeffrey T Mihalic, Xiaoqi Chen, Pingchen Fan, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibitionJeffrey T Mihalic, Pingchen Fan, Xiaoqi Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Identification of piperazine-bisamide GHSR antagonists for the treatment of obesityMing Yu, Mike Lizarzaburu, Holger Beckmann, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2008
Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agentsHilary P Beck, Todd Kohn, Steven Rubenstein, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of a new class of ghrelin receptor antagonistsJeffrey T Mihalic, Yong-Jae Kim, Mike Lizarzaburu, et al.
Molecular Cancer Therapeutics|February 15, 2014
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemiaKathleen Keegan, Cong Li, Zhihong Li, et al.
Pageof 11